Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Stendörren in connection with a tap issue of SEK 300 million bonds
Mandate

Vinge has advised Stendörren in connection with a tap issue of SEK 300 million bonds

October 04, 2018 Banking and Finance

Vinge has advised Stendörren Fastigheter AB (publ) (“Stendörren”) in connection with a tap issue of SEK 300 million senior unsecured floating rate bonds. 

The bonds have a tenor of three years and a floating interest rate of three months Stibor plus 4.25 per cent. The proceeds from the subsequent bond issue will be issued for general corporate purposes. Swedbank has acted as Issuing Agent and financial advisor to Stendörren.

In accordance with the terms and conditions, the subsequent bonds are intended to be listed and admitted to trading on the corporate bond list at Nasdaq Stockholm shortly.

Vinge also advised Stendörren in connection with the company’s initial bond issue of SEK 350 million on 18 June 2018. A listing prospectus was approved by the Swedish Financial Supervisory Authority on 1 August 2018.

Vinges team consisted of Louise Brorsson Salomon, André Isacson and Fredric Reissmüller.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

 HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

 Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026